Stanford Health Care
Final Thoughts on the Opioid Crisis and Normalizing Naloxone
The multidisciplinary panel of experts share final thoughts on strategies to normalize naloxone and decrease barriers to its obtainment and utilization.
Pain Contracts vs Agreements Between Clinicians and Patients
Charles Argoff, MD, leads a discussion on the use of pain contracts versus pain agreements between clinicians and patients to bring about desired outcomes.
Peer to Peer Discussion Initiatives and Telemedicine Impact
Experts discuss the need for and impact of peer-to-peer discussion initiatives, as well as the impact telemedicine utilization has had on the opioid crisis.
Role and Impact of Prescription Monitoring Programs
Experts share insights on how they have utilized Prescription Monitoring Programs to combat the opioid crisis and improve the safety of prescribed opioids.
Essential Patient Education Considerations for Naloxone
Experts share approaches to normalize conversations about naloxone with patients, as well as share important considerations for maximizing naloxone education.
Are Recommendations Infringing Upon Practice Autonomy?
Multidisciplinary panel of clinicians discuss whether recommendations made by national, state, and local agencies infringes upon clinical practice autonomy.
December 2020 CDC Health Alert Highlights and Implementation
Jeffrey Bratberg, PharmD, FAPhA, and Joshua Lynch, DO, EMT-P, FAAEM, FACEP, discuss highlights from the December 2020 CDC Health Alert and application.
Barriers to Naloxone Prescribing, Dispensing, and Utilization
Experts address barriers to overcome regarding naloxone prescribing, dispensing, and utilization that they have seen in the community.
Normalizing the Conversation about Naloxone with the Public
Multidisciplinary expert panel share perspectives on stigmatization and normalization of the conversation about naloxone between clinicians and patients.
Improving the Accessibility of Naloxone and Potential Impact
Joshua Lynch, DO, EMT-P, FAAEM, FACEP, shares ways to improve naloxone accessibility, and Theresa Mallick-Searle, MS, RN-BC, ANP-BC, discusses stigmatization.
Implementing Protocols, Policies, and Programs to Save Lives
Experts weigh in on protocols, policies, and programs that influence patient safety and address when a conversation should ensue with patients about naloxone.
New Labeling Requirements Put Forth by the FDA for Opioids
Theresa Mallick-Searle, MS, RN-BC, ANP-BC, shares her perspective on the new labeling requirements put forth by the FDA for opioids in regards to naloxone.
Risks for Accidental Opioid Overdose Seen in the Community
Joshua Lynch, DO, EMT-P, FAAEM, FACEP, highlight risks he has seen in the community for unintended users as well as patients for accidental opioid overdose.
Opioid Crisis Misconceptions and Unintended Consequences
Jeffrey Bratberg, PharmD, FAPhA, leads discussion tackling common opioid-related misconceptions as well as unintended consequences of the opioid crisis.
Current State of the Opioid Crisis: Multifaceted Point of View
Jeremy Adler, DMSc, PA-C, DFAAPA, leads discussion on elements that negatively impacts the quality of care for patients requiring pain management.
Unmet Needs and the Impact of COVID-19 on the Opioid Crisis
Experts discuss opioid crisis complexities, such as the able to manage pain appropriately and the impact of social and structural determinates of health.
2 Clarke Drive Cranbury, NJ 08512